But that hasnt happened, and the companys CEO said on its Q2 earnings call that the copycat GLP-1 market is of equal size to Novos business-likely due to the lower cost of compounded drugs
, , LEADER (Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results) - ( 3,5 ) 2 9340 2 - 1,8 () [55]
Higher concentrations generally take longer to dissolve
But it all starts with us
In further support of this notion, GLP-1R agonists can still reduce food intake when the aversive pathways of the AP are inhibited
INTEGRATED SERIVICES AND MANUFACTURING CAPABILITIES For specific customer applications, Nemera can support PenVario with the human factors and patient experience activities that must be integrated to ensure an efficient development process